DB
MED icon

Dmitry Balyasny’s Medifast MED Stock Holding History

Dmitry Balyasny’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-369
Closed -$42.6K – 2958
2022
Q4 		$42.6K Sell
369
-104,249
-100% -$12.1M ﹤0.01% 2369
2022
Q3 		$11.3M Buy
+104,618
New +$15M 0.03% 629
2022
Q2 		– Sell
-46,586
Closed -$7.96M – 2996
2022
Q1 		$7.96M Buy
+46,586
New +$8.78M 0.03% 775
2021
Q2 		– Sell
-3,234
Closed -$685K – 2191
2021
Q1 		$685K Sell
3,234
-9,732
-75% -$2.33M ﹤0.01% 1344
2020
Q4 		$2.55M Sell
12,966
-3,873
-23% -$684K 0.01% 822
2020
Q3 		$2.77M Buy
+16,839
New +$2.77M 0.02% 755
2020
Q2 		– Sell
-4,587
Closed -$287K – 1354
2020
Q1 		$287K Buy
+4,587
New +$418K ﹤0.01% 1000
2019
Q3 		– Sell
-21,442
Closed -$2.75M – 1409
2019
Q2 		$2.75M Sell
21,442
-29,533
-58% -$4.1M 0.02% 783
2019
Q1 		$6.5M Sell
50,975
-39,735
-44% -$5.04M 0.04% 505
2018
Q4 		$11.3M Buy
90,710
+53,237
+142% +$9.11M 0.08% 328
2018
Q3 		$8.3M Buy
37,473
+5,889
+19% +$1.19M 0.04% 544
2018
Q2 		$5.06M Buy
+31,584
New +$4.04M 0.02% 659
2018
Q1 		– Sell
-4,862
Closed -$339K – 2173
2017
Q4 		$339K Buy
+4,862
New +$323K ﹤0.01% 1696
2016
Q3 		– Sell
-8,394
Closed -$279K – 1162
2016
Q2 		$279K Buy
+8,394
New +$271K ﹤0.01% 941

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dmitry Balyasny's MED Position: Q1 2023 in Review

Dmitry Balyasny sold out of Medifast (MED) in Q1 2023, closing a stake of 369 shares — an estimated $42.6K sold.

Dmitry Balyasny first reported a position in MED in Q2 2016 and held it in 14 quarters. The position peaked at $11.3M in Q4 2018. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

  • Dmitry Balyasny reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 369 Medifast shares in Q1 2023, an estimated $42.6K.
  • Dmitry Balyasny first reported a position in Medifast in Q2 2016 and held it in 14 quarters.
  • Dmitry Balyasny's Medifast position peaked at $11.3M in Q4 2018.
  • 267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.